Compare Oscar Health Inc (OSCR) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Exxon Mobil Corporation — how do they compare? Oscar Health Inc trades at $28.84 (market cap $9.28B), while Exxon Mobil Corporation trades at $155.4 (market cap $628.83B). The key difference: Exxon Mobil Corporation is far larger — about 67.8× Oscar Health Inc's market cap, and Exxon Mobil Corporation pays a 2.72% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| OSCR | XOM | |
|---|---|---|
Market Cap | $9.28B | $628.83B |
Sector | Health | Energy |
52-Week High | $32.18 | $171.52 |
52-Week Low | $10.85 | $105.83 |
Enterprise Value | $4.90B | $668.06B |
Dividend Yield | — | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
ExxonMobil (XOM) trades at $154.45, up 4.1% on the day, reflecting strong momentum amid bullish technical signals and positive earnings beats. The stock is near its consensus price target of $170.63, with a P/E of 25.54 and solid profitability metrics, including a 7.76% net income margin. Recent news highlights Exxon's Permian Basin advantages and potential oil price spikes, though revenue has trended down from $398.7B in 2022 to $323.9B in 2025.
XOM presents a balanced outlook with upside to analyst targets and a stable dividend, but faces headwinds from declining revenue and net income. Investment appeal hinges on oil price stability and operational execution, while risks include volatile energy markets and geopolitical tensions. The bullish analyst consensus and strong balance sheet support a positive medium-term view.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
